Atul Saran - Feb 8, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: EVP, Chief Strat & Dev Officer
Signature: /s/ Jennifer Lynn Fox, Attorney-in-fact
Stock symbol: EBS
Transactions as of: Feb 8, 2023
Transactions value $: -$27,176
Form type: 4
Date filed: 2/10/2023, 07:35 PM
Previous filing: Mar 2, 2022
Next filing: Feb 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Award	$0	+95	+0.1%	$0.00	90.9K	Feb 8, 2023	Direct	F1
transaction	EBS	Common Stock	Tax liability	-$27.2K	-2.05K	-2.26%	$13.25	88.8K	Feb 8, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 5,792 shares of common stock, which is in excess of the 5,697 shares previously reported on February 25, 2020.
F2	Represents shares of common stock withheld to pay taxes.

Content

Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 5,792 shares of common stock, which is in excess of the 5,697 shares previously reported on February 25, 2020.

Represents shares of common stock withheld to pay taxes.